Real-time enrollment status for this ovarian neoplasms clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:08 PM UTC
| NCT Number | NCT07318558 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Neoplasms |
| Phase | PHASE3 |
| Target Enrollment | 900 participants |
| Active Locations | 27 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | October 13, 2026 (1 week ago) |
As of October 21, 2026: Clinical trial NCT07318558 is currently recruiting participants. This phase3 study for ovarian neoplasms is actively seeking new participants at 27 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07318558 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07318558 was last updated 1 week ago (October 13, 2026). HelloStudys verifies this status automatically.